Literature DB >> 1088942

Changes in monoamine oxidase and monoamines with human development and aging.

D S Robinson.   

Abstract

A series of studies of monoamines and their metabolism in a variety of human tissues indicate that there are aging effects that may alter neurotransmitter substances. Monoamine oxidase (MAO) activity has a significant positive correlation with age in plasma and blood platelets of normal subjects and patients suffering from depressive disorders. Monoamine oxidase and age correlate positively in hindbrain and in eight separate ares of human brains from patients who died from a variety of causes. Hindbrain norepinephrine concentration progressively decreases with advancing age (r equals -0.44, P less than 0.01) while no changes were noted for serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA). Hindbrain norepinephrine concentration has a significant negative correlation with MAO (r equals -0.41, P less than 0.025) and hindbrain 5-HIAA has a significant positive correlation with MAO (r equals +0.66, P equals less than 0.05). These studies suggest that aging processes may significantly affect monoamine mechanisms and be a predisposing factor to the development of clinical diseases in man such as depression, parkinsonism and other disorders of central nervous system homeostasis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1088942

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  21 in total

Review 1.  Tailoring adult psychiatric practices to the field of geriatrics.

Authors:  B S Greenwald; N Kremen; P Aupperle
Journal:  Psychiatr Q       Date:  1992

Review 2.  Selegiline and Parkinson's disease. Protective and symptomatic considerations.

Authors:  L I Golbe; J W Langston; I Shoulson
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  Pituitary physiological and ultrastructural changes during aging.

Authors:  A C Nessi; G De Hoz; C Tanoira; E Guaraglia; G Consens
Journal:  Endocrine       Date:  1995-10       Impact factor: 3.633

4.  Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex.

Authors:  M D Galva; G P Bondiolotti; M Olasmaa; G B Picotti
Journal:  J Neural Transm Gen Sect       Date:  1995

5.  Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

Authors:  B Saletu; N Brandstätter; M Metka; M Stamenkovic; P Anderer; H V Semlitsch; G Heytmanek; J Huber; J Grünberger; L Linzmayer
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

6.  Alterations in the hippocampus of aged mice.

Authors:  C H Lamar; E J Hinsman; C K Henrikson
Journal:  Acta Neuropathol       Date:  1976-12-21       Impact factor: 17.088

Review 7.  Depression in the elderly: the role of the primary care physician in management.

Authors:  J F McGreevey; K Franco
Journal:  J Gen Intern Med       Date:  1988 Sep-Oct       Impact factor: 5.128

Review 8.  Drugs and depression.

Authors:  F A Whitlock; L E Evans
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

9.  The effect of age on the activity and molecular properties of human brain monoamine oxidase.

Authors:  C J Fowler; A Wiberg; L Oreland; J Marcusson; B Winblad
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

10.  Dopamine agonist 3-PPP fails to protect against MPTP-induced toxicity.

Authors:  Dhanasekaran Muralikrishnan; Manuchair Ebadi; Holly M Brown-Borg
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.